Insulet Corporation (PODD:NASDAQ) closed at $152.48 on November 13, 2026, up 2.14% on the day. The stock trades 57.0% below its 52-week high of $354.88 and 20.6% above its 52-week low of $126.40. Over the past year, it lost 54.2%. Insulet Corporation is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since November 13, 2025, PODD closed higher on 119 days (47%). Its best day was April 30, 2026 (+7.57%) and its worst was August 5, 2026 (-20.12%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
Insulet Corporation, a medical device company, develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.
Find more stocks like PODD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.